These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2115030)

  • 1. Treatment of experimental suprachoroidal hemorrhage with intravenous tissue plasminogen activator.
    Liu JC; Peyman GA; Oncel M
    Int Ophthalmol; 1990 Jul; 14(4):267-70. PubMed ID: 2115030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of experimental suprachoroidal hemorrhage with subconjunctival injection of tissue plasminogen activator: a negative report.
    Liu JC; Peyman GA; Oncel M
    Ophthalmic Surg; 1990 Sep; 21(9):641-3. PubMed ID: 2123529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of suprachoroidal hemorrhage with tissue plasminogen activator.
    Kwon OW; Kang SJ; Lee JB; Lee SC; Yoon YD; Oh JH
    Ophthalmologica; 1998; 212(2):120-5. PubMed ID: 9486552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suprachoroidal hemorrhage: no longer a disaster.
    Spaeth GL
    Ophthalmic Surg; 1987 May; 18(5):329-30. PubMed ID: 3496568
    [No Abstract]   [Full Text] [Related]  

  • 5. The use of viscoelastic substances in the drainage of postoperative suprachoroidal hemorrhage.
    Baldwin LB; Smith TJ; Hollins JL; Pearson PA
    Ophthalmic Surg; 1989 Jul; 20(7):504-7. PubMed ID: 2674814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-type plasminogen activator-assisted drainage of suprachoroidal hemorrhage showing a kissing configuration.
    Murata T; Kikushima W; Imai A; Toriyama Y; Tokimitsu M; Kurokawa T
    Jpn J Ophthalmol; 2011 Jul; 55(4):431-432. PubMed ID: 21647568
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of viscoelastic substances in the drainage of postoperative suprachoroidal hemorrhage.
    Shin DH; Frenkel RE
    Ophthalmic Surg; 1989 Dec; 20(12):895. PubMed ID: 2630973
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of experimental vitreous hemorrhage with tissue plasminogen activator.
    Min WK; Kim YB; Lee KM
    Korean J Ophthalmol; 1990 Jun; 4(1):12-5. PubMed ID: 2120486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repetitive low-dose tissue plasminogen activator for the clearance of experimental vitreous hemorrhage.
    Min WK; Kim YB; Ahn BH; Seong GH
    Korean J Ophthalmol; 1994 Dec; 8(2):45-8. PubMed ID: 7853730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2,2,6, 6-tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.
    Lapchak PA; Chapman DF; Zivin JA
    Stroke; 2001 Jan; 32(1):147-53. PubMed ID: 11136930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of intra-arterial and intravenous tissue-type plasminogen activator on autologous arterial emboli in the cerebral circulation of rabbits.
    Hamilton MG; Lee JS; Cummings PJ; Zabramski JM
    Stroke; 1994 Mar; 25(3):651-5; discussion 656. PubMed ID: 8128521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of tissue plasminogen activator in experimental hyphema.
    Lambrou FH; Snyder RW; Williams GA
    Arch Ophthalmol; 1987 Jul; 105(7):995-7. PubMed ID: 3111453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of postoperative suprachoroidal hemorrhage with continuous-infusion air pump.
    Abrams GW; Thomas MA; Williams GA; Burton TC
    Arch Ophthalmol; 1986 Oct; 104(10):1455-8. PubMed ID: 3490249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expulsive choroidal hemorrhage in rabbits. A histopathologic study.
    Beyer CF; Peyman GA; Hill JM
    Arch Ophthalmol; 1989 Nov; 107(11):1648-53. PubMed ID: 2818287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous suprachoroidal hemorrhage secondary to thrombolysis for the treatment of myocardial infarction.
    Barsam A; Heatley CJ; Herbert L
    Clin Exp Ophthalmol; 2006 Mar; 34(2):177-9. PubMed ID: 16626438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of subconjunctivally injected liposome-encapsulated tissue plasminogen activator on the absorption rate of subconjunctival hemorrhages in rabbits.
    Han SB; Baek SH; Park JS; Yang HK; Kim JY; Kim CK; Hwang JM
    Cornea; 2011 Dec; 30(12):1455-60. PubMed ID: 21955629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental and clinical observations on massive suprachoroidal hemorrhage.
    Lakhanpal V
    Trans Am Ophthalmol Soc; 1993; 91():545-652. PubMed ID: 8140705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intravitreal tissue plasminogen activator on experimental subretinal hemorrhage.
    Coll GE; Sparrow JR; Marinovic A; Chang S
    Retina; 1995; 15(4):319-26. PubMed ID: 8545578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the spin trap agent disodium- [tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit Large clot embolic stroke model: combination studies with tissue plasminogen activator.
    Lapchak PA; Araujo DM; Song D; Wei J; Purdy R; Zivin JA
    Stroke; 2002 Jun; 33(6):1665-70. PubMed ID: 12053009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator treatment of experimental subretinal hemorrhage.
    Johnson MW; Olsen KR; Hernandez E
    Retina; 1991; 11(2):250-8. PubMed ID: 1925092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.